SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SANUWAVE Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.83−0.13 (-2.62%)
Close on Oct 19, 2026
- Market cap
- $41.54M
- P/E (TTM)
- 11.8
- Dividend yield
- –
Share price
−$29.10 (−85.76%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
SANUWAVE Health, Inc. grew revenue 12.7% to $44.02M over the twelve months to Jun 30, 2026. Operating income fell 72.9% to $1.50M, moving the operating margin from 14.2% to 3.4%. Free cash flow was $4.24M.
Revenue
$44.02M
+12.7% vs. a year earlier
Operating income
$1.50M
-72.9% vs. a year earlier
Free cash flow
$4.24M
TTM Q2 2026
EPS, diluted
$0.41
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $41.54M
- P/E ratio
- 11.8
- Price to sales
- 0.94
- Price to book
- 14.91
- Dividend yield
- –
- Free cash flow yield
- 10.22%
Fundamentals
- Revenue
- $44.02M
- Net income
- $15.26M
- EPS, diluted
- $0.41
- Free cash flow
- $4.24M
- Book value per share
- $0.32
- Diluted shares
- 9M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$44.02M+12.7% YoY
Gross profit
$33.60M+10.8% YoY
Operating income
$1.50M-72.9% YoY
Net income
$15.26M
EPS, diluted
–
Free cash flow
$4.24M
Reported periodTrailing twelve months